ID: ALA3409535

Max Phase: Preclinical

Molecular Formula: C21H24Li2N3O7P

Molecular Weight: 463.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](NP(=O)([O-])CNC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)[O-].[Li+].[Li+]

Standard InChI:  InChI=1S/C21H26N3O7P.2Li/c1-15(19(25)23-18(20(26)27)12-16-8-4-2-5-9-16)24-32(29,30)14-22-21(28)31-13-17-10-6-3-7-11-17;;/h2-11,15,18H,12-14H2,1H3,(H,22,28)(H,23,25)(H,26,27)(H2,24,29,30);;/q;2*+1/p-2/t15-,18-;;/m0../s1

Standard InChI Key:  AQGRKKWLKYBFLA-WQPBPYDNSA-L

Associated Targets(non-human)

Thermolysin 425 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 463.43Molecular Weight (Monoisotopic): 463.1508AlogP: 1.85#Rotatable Bonds: 11
Polar Surface Area: 154.06Molecular Species: ACIDHBA: 5HBD: 5
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.01CX Basic pKa: CX LogP: 1.58CX LogD: -3.86
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.32Np Likeness Score: -0.06

References

1. Nasief NN, Hangauer D..  (2015)  Additivity or cooperativity: which model can predict the influence of simultaneous incorporation of two or more functionalities in a ligand molecule?,  90  [PMID:25559080] [10.1016/j.ejmech.2014.11.056]

Source